Avista Capital, Hamilton Lane announce partnership in Cosette Pharmaceuticals

Avista Capital Partners, a New York-based private equity firm focused exclusively on healthcare, and Hamilton Lane announced that funds managed by Hamilton Lane have acquired a significant equity interest in Cosette Pharmaceuticals, a US-based specialty pharmaceutical company, from Avista and its co-investors. Avista and these funds managed by Hamilton Lane will jointly control Cosette going forward, with a focus on accelerating innovation and growth. Since Avista’s initial investment in Cosette in December 2018, and under the leadership of a new executive management team, Cosette has successfully launched new and innovative products across its portfolio through a significant R&D effort as well as acquisitions and licensing deals which have expanded the company’s presence across existing and new markets. This includes the recent acquisition of Ambien and Ambien CR in the United States from Sanofi US. These initiatives have led to robust historic EBITDA growth and free cash flow generation while positioning Cosette to capitalize on compelling opportunities ahead.